EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Persistence of blaCTX-M-15 Dominance in ESBL-Producing Escherichia coli and Klebsiella pneumoniae Strains: A Single-Center Study

Muhammad Azreen Bin Mat Husin, Tiew Hung Ting, Raja Mohd Fadhil Raja Abd Rahman, Ramliza Ramli, Ilana Lopes Baratella da Cunha Camargo, Nor Azila Muhammad Azami, Sheila Nathan, Hui-min Neoh

Jundishapur Journal of Microbiology · 30.06.2026 · 19 (6)

DOI: 10.5812/jjm-171587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jundishapur Journal of Microbiology, online erschienen am 30.06.2026. Verfasst von Muhammad Azreen Bin Mat Husin und 7 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Infections caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae limit treatment options and increase reliance on last-line antibiotics. Although blaCTX-M-15 is the globally dominant ESBL genotype, recent data on its persistence in individual Malaysian hospitals are limited.

Objectives

This study aimed to determine the prevalence and temporal persistence of blaCTX-M-15 among ESBL-producing E. coli (ESBLEC) and K. pneumoniae (ESBLKP) isolates from a tertiary care center over a 2-year period. Evidence Acquisition: ESBLEC and ESBLKP strains were collected from Hospital Canselor Tuanku Muhriz (HCTM) during two sampling periods: June 2022 to January 2023 and December 2023 to March 2024. Antimicrobial susceptibility testing was performed using VITEK 2, and results were retrieved through the WHONET system. ESBL genes were detected by PCR, and blaCTX-M-15 was subtyped among blaCTX-M-1-positive strains.

Results

Blood and urine were the predominant sources of ESBL isolates in both sampling periods. blaCTX-M-1 was the most prevalent ESBL gene in both species. Among blaCTX-M-1-positive strains, blaCTX-M-15 persisted at high prevalence in ESBLEC (68.5% and 66.7% in the two sampling periods, respectively) and ESBLKP (92.9% in both sampling periods); however, temporal continuity across the unsampled interval remains unknown. The proportion of ESBLEC strains resistant to ceftazidime (CAZ) and cefepime (FEP) decreased during the 10-month interval from February to November 2023, whereas ESBLKP resistance profiles remained largely stable. Conclusions: blaCTX-M-15 remains dominant in HCTM, underscoring the need for continued molecular surveillance and antimicrobial stewardship.

Zitieren

APA

Husin, M. A. B. M., Ting, T. H., Rahman, R. M. F. R. A., Ramli, R., Camargo, I. L. B. D. C., Azami, N. A. M., Nathan, S., & Neoh, H. (2026). Persistence of blaCTX-M-15 Dominance in ESBL-Producing Escherichia coli and Klebsiella pneumoniae Strains: A Single-Center Study. Jundishapur Journal of Microbiology, 19(6). https://doi.org/10.5812/jjm-171587

Vancouver

Husin MABM, Ting TH, Rahman RMFRA, Ramli R, Camargo ILBDC, Azami NAM, et al. Persistence of blaCTX-M-15 Dominance in ESBL-Producing Escherichia coli and Klebsiella pneumoniae Strains: A Single-Center Study. Jundishapur Journal of Microbiology. 2026;19(6). doi:10.5812/jjm-171587

BibTeX
@article{Husin2026,
  author = {Husin, Muhammad Azreen Bin Mat and Ting, Tiew Hung and Rahman, Raja Mohd Fadhil Raja Abd and Ramli, Ramliza and Camargo, Ilana Lopes Baratella da Cunha and Azami, Nor Azila Muhammad and Nathan, Sheila and Neoh, Hui-min},
  title = {Persistence of blaCTX-M-15 Dominance in ESBL-Producing Escherichia coli and Klebsiella pneumoniae Strains: A Single-Center Study},
  journal = {Jundishapur Journal of Microbiology},
  year = {2026},
  volume = {19},
  number = {6},
  doi = {10.5812/jjm-171587}
}
Kostenlos starten →